Episode 122: NCI Director Shares Research and Innovation During COVID-19
Norman “Ned” Sharpless, MD, director of the National Cancer Institute (NCI), joins Lisa Kennedy Sheldon, PhD, ANP-BC, AOCNP®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss NCI’s COVID-19 coronavirus research efforts, how the agency is partnering with oncology nurses to understand the best care for patients with COVID-19 and cancer, nursing innovation during the pandemic, and the implications of delayed screening and care on future cancer incidence rates.
Episode Notes
Check out these resources related to today’s episode:
- The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities.
- Oncology Nursing Podcast Episode 106: NINR Director Discusses Nursing Research Amid COVID-19
- ONS Voice article: Federal Agencies Collaborate; Nurse Proposes Healthcare Bill; NCI Shifts Research to COVID-19
- ONS Voice article: NCI Cancer Research Persists Despite COVID-19 Limitations
- ONS Recommendations for Oncology Staff Assignments During the COVID-19 Pandemic
- ONS Interim Guidelines During the COVID-19 Pandemic
- Dr. Sharpless’s Science Editorial on COVID-19 and Cancer
- Childhood Cancer Data Initiative (CCDI)
- The NCI Bottom Line Blog
- NCI Community Oncology Research Program (NCORP)
- NCI COVID-19 in Cancer Patients Study
- NCI’s COVID-19 Information for Cancer Researchers
- NCI-MATCH Trial
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Listen on:
Listen on Apple Podcasts, Listen on Google Podcasts, Listen on Stitcher, Listen on Spotify, Listen on Amazon Music